NASDAQ:SRTS Stock Quote
Sensus Healthcare Inc is a medical technology company that specializes in developing innovative solutions for the treatment of non-melanoma skin cancers and other dermatological conditions
The company focuses on providing non-invasive and effective therapies, particularly through its proprietary Sensus device that utilizes ultrasound technology for the precise targeting of cancerous tissues. In addition to skin cancer treatment, Sensus Healthcare also explores applications in other areas of oncology and dermatology, aiming to improve patient outcomes while minimizing side effects associated with traditional treatment methods. The company's commitment to research and development allows it to drive advancements in medical care, enhancing the quality of life for patients.
Frequently Asked Questions
Are there clinical studies supporting Sensus Healthcare's treatments?
Yes, Sensus Healthcare's treatments are supported by various clinical studies and research that demonstrate their effectiveness and safety in treating skin cancers. The company collaborates with medical professionals to conduct clinical trials, ensuring that their technologies are backed by scientific evidence.
Can patients expect side effects from Sensus treatments?
While every medical treatment can carry some level of risk, Sensus Healthcare's non-invasive treatment systems are associated with fewer side effects compared to traditional surgical options. Patients might experience mild skin irritation or redness at the site of treatment, but serious side effects are generally rare, and many patients find the procedures to be well-tolerated.
Does Sensus Healthcare engage in partnerships or collaborations?
Yes, Sensus Healthcare actively seeks partnerships and collaborations with research institutions, medical professionals, and technology companies to foster innovation and improve its treatment solutions. These collaborations can lead to advancements in technology, better clinical outcomes, and enhanced patient care.
Does Sensus Healthcare invest in research and development?
Yes, Sensus Healthcare places a strong emphasis on research and development to drive innovation and improve its product offerings. The company allocates significant resources to R&D, aiming to enhance their existing technologies while exploring new treatment solutions that can optimize patient care in the field of dermatology.
Has Sensus Healthcare received any regulatory approvals?
Sensus Healthcare's treatment systems have received necessary regulatory approvals from the U.S. Food and Drug Administration (FDA), allowing the products to be marketed and sold in the United States. Compliance with regulatory standards ensures that their devices meet safety and efficacy requirements for patient use.
How can investors access information about Sensus Healthcare, Inc.?
Investors can access detailed information about Sensus Healthcare, Inc. through several channels, including the company's official website, financial filings available on the NASDAQ website, investor relations communications, and earnings calls. These resources provide insights into the company’s financial performance, product developments, and strategic initiatives.
How does Sensus Healthcare market its products?
Sensus Healthcare employs a multi-faceted marketing strategy that includes direct sales to healthcare professionals, educational outreach, attendance at medical conferences, and partnerships with industry leaders. By raising awareness about the effectiveness of their products, the company aims to reach healthcare providers who can benefit from their innovative treatment solutions.
Is Sensus Healthcare, Inc. publicly traded?
Yes, Sensus Healthcare, Inc. is publicly traded on the NASDAQ stock exchange under the ticker symbol SRTS. Being a publicly traded company allows it to raise capital through equity markets and provides greater visibility to investors and stakeholders.
What are the benefits of using Sensus Healthcare's treatment systems?
The treatment systems developed by Sensus Healthcare provide several benefits, including reduced side effects compared to traditional surgical options, minimal downtime for patients, and typically high success rates in treating skin cancers. Additionally, the non-invasive nature of their treatments allows for greater patient comfort and convenience.
What are the future growth prospects for Sensus Healthcare?
Sensus Healthcare has promising growth prospects driven by increasing awareness of non-invasive treatment options for skin cancers, ongoing clinical research and development, and a growing patient population. As the demand for innovative healthcare solutions continues to rise, the company is well-positioned to expand its market share and enhance its product offerings.
What differentiates Sensus Healthcare from its competitors?
Sensus Healthcare differentiates itself from competitors through its commitment to non-invasive treatment solutions that leverage advanced technology, such as low-energy x-ray therapy. This focus on patient-centric treatment options, along with a strong emphasis on clinical research and innovation, allows Sensus to provide effective alternatives that are less disruptive than traditional surgical approaches.
What does Sensus Healthcare, Inc. do?
Sensus Healthcare, Inc. is a medical technology company that specializes in the development and commercialization of innovative, non-invasive, and non-surgical treatment solutions for skin cancer and other dermatological conditions. Their flagship product, the Sensus treatment system, utilizes low-energy x-ray technology to provide precise and effective treatment options to patients, focusing primarily on skin cancers such as basal cell carcinoma and squamous cell carcinoma.
What is the company's vision and mission?
Sensus Healthcare's vision is to be a leader in dermatologic treatment technologies that prioritize patient safety, comfort, and effective outcomes. Their mission is to provide accessible, innovative, non-invasive treatment solutions that empower patients and healthcare providers in the fight against skin cancer.
What is the Sensus treatment system?
The Sensus treatment system is the company's flagship product that utilizes low-energy x-ray technology to treat non-melanoma skin cancers. This system allows healthcare providers to deliver targeted therapy to patients with a high level of precision, minimizing collateral damage to surrounding healthy tissue and promoting faster healing.
What markets does Sensus Healthcare operate in?
Sensus Healthcare primarily operates in the dermatology and oncology markets, focusing on the treatment of skin cancers and benign skin conditions. The company is dedicated to expanding its market presence both in the United States and internationally, targeting regions with a growing demand for advanced dermatologic treatments.
What type of products does Sensus Healthcare, Inc. offer?
Sensus Healthcare, Inc. offers a range of medical devices and technologies designed for the treatment of skin cancer and certain benign skin conditions. Their primary product line includes the Sensus system, which is designed to treat non-melanoma skin cancers by delivering low-energy x-ray therapy directly to the targeted area without the need for incision or surgical intervention.
When was Sensus Healthcare, Inc. founded?
Sensus Healthcare, Inc. was founded in 2010, driven by a commitment to developing less invasive treatment alternatives for patients suffering from skin cancer. Over the years, the company has evolved and expanded its product offerings to provide advanced solutions aimed at improving patient outcomes.
Where is Sensus Healthcare, Inc. headquartered?
Sensus Healthcare, Inc. is headquartered in Boca Raton, Florida. This location allows the company to access a vibrant medical community and maintain proximity to research institutions, which are important for its continued innovation and development of new treatment technologies.
Who are the target customers for Sensus Healthcare, Inc.?
The primary customers of Sensus Healthcare, Inc. include healthcare providers such as dermatologists, oncologists, and medical clinics that specialize in the treatment of skin cancers and other dermatological conditions. Additionally, the company serves hospitals and outpatient surgical centers that require effective, non-invasive treatment options for their patients.
What is the current price of Sensus Healthcare, Inc. - Common Stock?
The current price of Sensus Healthcare, Inc. - Common Stock is 4.920
When was Sensus Healthcare, Inc. - Common Stock last traded?
The last trade of Sensus Healthcare, Inc. - Common Stock was at 2:12 pm EDT on April 2nd, 2025
What is the market capitalization of Sensus Healthcare, Inc. - Common Stock?
The market capitalization of Sensus Healthcare, Inc. - Common Stock is 81.16M
How many shares of Sensus Healthcare, Inc. - Common Stock are outstanding?
Sensus Healthcare, Inc. - Common Stock has 16.50M shares outstanding.